Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regen BioPharma
AddedFeb 19, 2024
UpdatedJun 18, 2026
Regen BioPharma

Regen BioPharma

Public

US-based Regen BioPharma develops and commercializes stem cell therapies for diabetes, heart, and lung diseases.

HQ
La Mesa, CA, US
Founded
2012
Overview
Compare
Employees
Website

Regen BioPharma, Inc. focuses on developing and commercializing stem cell therapies aimed at treating diabetes, heart-related illnesses, circulatory issues, and Chronic Obstructive Pulmonary Disease (COPD). The company's core mission is to advance translational medicine platforms to obtain regulatory approval and execute clinical trials in cell therapy. Based in La Mesa, United States, Regen BioPharma aims to bring innovative medical solutions to market, addressing significant unmet medical needs.

Regen BioPharma has made notable strides in the biotechnology sector, particularly in stem cell research and therapy development. The company actively engages with individual and institutional investors, advisors, and analysts through platforms like the Emerging Growth Conference, where it outlines its goals and strategic direction. The leadership includes a proactive Chairman and Chief Executive Officer who regularly communicates with shareholders, underscoring the company's commitment to transparency and growth.

Regen BioPharma - Similar Companies

Regenerative Medical Solutions logo

Regenerative Medical Solutions

Regenxbio logo

Regenxbio

regenxbio.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Regenemed logo

Regenemed

regenemed.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

ViaCyte logo

ViaCyte

BioRegenx logo

BioRegenx

bioregenx.com

InGeneron logo

InGeneron

ingeneron.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Stemgenics logo

Stemgenics

stemgenics.com

Regenacy Pharmaceuticals logo

Regenacy Pharmaceuticals

Regennova logo

Regennova

regennova.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Endogena Therapeutics logo

Endogena Therapeutics

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Regen BioPharma - Quick Facts

Who are Regen BioPharma's competitors?

Companies similar to Regen BioPharma include Regenerative Medical Solutions, Regenxbio, RegeneRx Biopharmaceuticals and Regenemed.

When was Regen BioPharma founded?

Regen BioPharma was founded in 2012.

Where is Regen BioPharma's headquarters located?

Regen BioPharma's headquarters is located in La Mesa, CA, US.

How many employees does Regen BioPharma have?

Regen BioPharma has 2 employees as of Feb 5, 2024.

Regen BioPharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Stem Cell Therapies
Tags
  • Healthtech
Unique IDs
  • ein: 455192997
  • secCik: 0001589150
  • ticker: RGBP
  • ticker: RGBPP
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research